Research map: Mainstream and fast-track genetic testing in pancreatic cancer patients and its impact on treatment: our experience in a tertiary hospital in Spain

Back to the article

Papers in this map

  1. Increased Survival in Pancreatic Cancer with nab-Paclitaxel plus Gemcitabine · Daniel D. Von Hoff · 2013 · 6834 citations · Cited by this paper
  2. Colonoscopy findings and polyp pathology in CHEK2 carriers: a single center experience · 2026 · Related
  3. Maintenance Olaparib for Germline BRCA -Mutated Metastatic Pancreatic Cancer · Talia Golan · 2019 · 2327 citations · Cited by this paper
  4. Familial risks in prostate cancer between brothers and half-brothers as clues to germline genetic and environmental causes · 2026 · Related
  5. Pancreatic cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up · Thierry Conroy · 2023 · 593 citations · Cited by this paper
  6. Attenuated Li–Fraumeni syndrome with TP53 p.R181H in a Japanese patient with metastatic rectal adenocarcinoma: a case report · 2026 · Related
  7. Five-Year Outcomes of FOLFIRINOX vs Gemcitabine as Adjuvant Therapy for Pancreatic Cancer · Thierry Conroy · 2022 · 347 citations · Cited by this paper
  8. Patient-derived outcome assessment of knowledge, communication, and management in those diagnosed with BAP1-tumor predisposition syndrome · 2026 · Related
  9. The Multicenter Cancer of Pancreas Screening Study: Impact on Stage and Survival · Mohamad H. Dbouk · 2022 · 248 citations · Cited by this paper
  10. Breast cancer phenotypes in carriers of pathogenic POT1 variants · 2026 · Related
  11. Overall Survival Results From the POLO Trial: A Phase III Study of Active Maintenance Olaparib Versus Placebo for Germline BRCA-Mutated Metastatic Pancreatic Cancer · Hedy Lee Kindler · 2022 · 243 citations · Cited by this paper
  12. Homozygous TP53 alterations: a case of a biallelic splice variant and a brief review of the literature · 2026 · Related
  13. Implementing rapid, robust, cost-effective, patient-centred, routine genetic testing in ovarian cancer patients · Angela Joy George · 2016 · 232 citations · Cited by this paper
  14. Genotypic and phenotypic characteristics of germline TP53 variant carriers: experience from two cancer genetic counseling units · 2026 · Related
  15. Evaluation of a Streamlined Oncologist-Led BRCA Mutation Testing and Counseling Model for Patients With Ovarian Cancer · Nicoletta Colombo · 2018 · 99 citations · Cited by this paper
  16. When screentime fails: initiative to improve completion of hereditary cancer genetic testing after telemedicine counseling · 2026 · Related
  17. SEOM clinical guidelines in hereditary breast and ovarian cancer (2019) · the SEOM Hereditary Cancer Working Group · 2019 · 74 citations · Cited by this paper
  18. Trends in breast reconstruction for BRCA1/2, PALB2 and other high penetrance germline pathogenic variant carriers undergoing risk reducing mastectomy · 2026 · Related
  19. Mainstream consent programs for genetic counseling in cancer patients: A systematic review · Tahlia Scheinberg · 2020 · 70 citations · Cited by this paper
  20. Biallelic germline MBD4 mutations predispose to colorectal polyposis, hypermutated AML, and schwannomas · 2026 · Related
  21. Efficacy of platinum-based chemotherapy and prognosis of patients with pancreatic cancer with homologous recombination deficiency: comparative analysis of published clinical studies · Илья Анатольевич Покатаев · 2020 · 54 citations · Cited by this paper
  22. Evaluation of a Mainstream Model of Genetic Testing for Men With Prostate Cancer · Tahlia Scheinberg · 2020 · 52 citations · Cited by this paper
  23. SEOM clinical guidelines for pancreatic and biliary tract cancer (2020) · María Auxiliadora Gómez‐España · 2021 · 48 citations · Cited by this paper
  24. Implementing Systematic Genetic Counseling and Multigene Germline Testing for Individuals With Pancreatic Cancer · Anu B. Chittenden · 2021 · 42 citations · Cited by this paper
  25. Mainstreaming germline genetic testing for patients with pancreatic cancer increases uptake · Mitchell L. Ramsey · 2022 · 39 citations · Cited by this paper
  26. Referral frequency, attrition rate, and outcomes of germline testing in patients with pancreatic adenocarcinoma · Evan Justin Walker · 2018 · 30 citations · Cited by this paper
  27. Personalizing Medicine With Germline and Somatic Sequencing in Advanced Pancreatic Cancer: Current Treatments and Novel Opportunities · Michael SW Lee · 2021 · 28 citations · Cited by this paper
  28. Universal Genetic Testing for Newly Diagnosed Invasive Breast Cancer · Zoulikha Rezoug · 2024 · 28 citations · Cited by this paper
  29. SEOM clinical guideline on hereditary colorectal cancer (2019) · Carmen Guillén‐Ponce · 2020 · 19 citations · Cited by this paper
  30. Satisfaction With Clinician-Led Germline Genetic Counseling in Patients With Prostate Cancer · Sophia M. Abusamra · 2022 · 14 citations · Cited by this paper
  31. Genetic Testing Among Patients with High-Risk Breast, Ovarian, Pancreatic, and Prostate Cancers · Nina M. Clark · 2022 · 14 citations · Cited by this paper
  32. Clinical Impact of a Rapid Genetic Testing Model for Advanced Prostate Cancer Patients · Kelsey E. Breen · 2023 · 14 citations · Cited by this paper
  33. Patients’ experiences with pre-test genetic counseling provided by breast cancer healthcare professionals: Results from a large prospective multicenter study · Kyra Bokkers · 2023 · 13 citations · Cited by this paper
  34. SEOM clinical guideline on heritable TP53-related cancer syndrome (2022) · Ana Beatriz Sánchez‐Heras · 2023 · 11 citations · Cited by this paper
  35. Mainstream Germline Genetic Testing with Expanded Eligibility for Early Breast Cancer Patients in a Large Integrated Health System · Veronica Shim · 2024 · 10 citations · Cited by this paper
  36. Untitled · Cited by this paper

Source: OpenAlex (CC0)